Live Breaking News & Updates on Christine Bestvina

Stay updated with breaking news from Christine bestvina. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Liquid biopsy: A new tool for identifying and monitoring cancer

Liquid biopsy: A new tool for identifying and monitoring cancer
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Christine Bestvina , University Of Chicago Medical Center , University Of Chicago Medicine , Chicago Medical Center , Chicago Medical , Chicago Medicine , Sari Rosenberg ,

Taletrectinib Continues to Demonstrate High Clinical Activity in Advanced ROS1+ NSCLC

Clinicians discuss data on the ROS1 TKI taletrectinib in patients with locally advanced or metastatic ROS1-positive non–small cell lung cancer. ....

New York , United States , J Thor Onc , Christine Bestvina , Stephenv Liu , Alexander Drilon , Jason Porter , China National Medical Products Administration , Cancer Center , University Of Chicago Medicine Comprehensive Cancer Center , Georgetown University , National Medical Products Administration Of China , Research Institute , Lung Cancer Disease Research Group , Georgetown Lombardi Comprehensive Cancer Center , West Cancer Center , National Medical Products Administration , Thoracic Oncology , Developmental Therapeutics , Georgetown Lombardi Comprehensive Cancer , Early Drug Development Service , Memorial Sloan Kettering Cancer Center , Uchicago Medicine Comprehensive Cancer Center , Heart Therapeutics , Anheart Therapeutics , Ros1 Tki ,

Dr Bestvina on the Management of AEs Associated With Repotrectinib in ROS1+ NSCLC

Christine Bestvina, MD, discusses strategies for managing adverse effects associated with the ROS1 TKI repotrectinib in patients with ROS1-positive metastatic non–small cell lung cancer. ....

Christine Bestvina , University Of Chicago Medicine , Department Of Medicine , Chicago Medicine , Lung Cancer , Ros1 Positive , Ugtyro ,

TKI Plus Immunotherapy Active in Melanoma After Anti-PD-1 Progression

More than a fifth of patients responded to lenvatinib-pembrolizumab combination ....

United States , Comunidad Autonoma De Cataluna , Jason Luke , Christine Bestvina , Charles Bankhead , University Of Pittsburgh Hillman Cancer Center , American Society Of Clinical Oncology , University Of Chicago Comprehensive Cancer Center , Ana Arance , Hospital Clinic Barcelona , Clinical Oncology , Pittsburgh Hillman Cancer Center , Chicago Comprehensive Cancer Center , Medpage Today ,

Immunotherapy Rechallenge in NSCLC Yields Overall Survival Boost

Phase II trial sees 'synergistic benefit' with checkpoint blockade and anti-angiogenesis ....

United States , University Of Chicago , Christine Bestvina , Los Angeles , Karen Reckamp , Sinai Medical Center , American Society Of Clinical Oncology , University Of Chicago Comprehensive Cancer Center , Eastern Cooperative Oncology Group , Cedars Sinai Medical Center , American Society , Clinical Oncology , Chicago Comprehensive Cancer Center , Managing Editor , Medpage Today ,